Healthcare
NVIDIA advances AI for protein design and cancer care
NVIDIA is expanding healthcare AI collaborations in protein design, drug discovery, and adaptive cancer radiotherapy.
NVIDIA announced collaborations focused on AI-powered protein design, drug discovery, and personalized cancer treatment. One initiative involves an open protein-design model developed with the University of Washington’s Institute for Protein Design. Another collaboration with Siemens Healthineers will explore AI-enabled adaptive radiotherapy. The work aims to support patient-specific treatment planning, simulation, and real-time computing in cancer care.
Original source: Digital Health News